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The broad public record on AneuRx (including the FDA’s
Public Health Notifications), combined with the experience of
more than 40,000 patients in the United States, confirm that
AneuRx is a safe, effective, and important treatment option for
adults with potentially deadly abdominal aortic aneurysms. As
reported in Medtronic’s 2004 clinical update, US clinical results
from a total of 1193 patients (using Kaplan-Meier analyses) at 5
years are as follows:
● freedom from rupture rate of 97.2%
● freedom from surgical conversion rate of 91.1%
● freedom from aneurysm-related death rate of 96.8%
● probability of survival rate, based on all-cause mortality, of
61.5%
Going forward, Medtronic will continue to act, as necessary,
to ensure that our proprietary clinical data are used appropriately
and interpreted properly in the public domain.
We thank those clinical researchers who have had the vision
and drive to develop new and less invasive therapies for abdominal
aortic aneurysms, and we remain committed to restoring health
and extending life for the thousands of patients with this life-
threatening disease.
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Regarding “Ethics of boutique medical practice”
The article in the June issue of the Journal by Jones et al
entitled “Ethics of boutique medical practice” (J Vasc Surg 2004;
39:1354-5) raises timely and important ethical issues that physi-
cians and health care consumers need to analyze and confront. We
would like to address a number of points made in the article that
could serve as a further basis for discussion on providing this type
of care.
It is noteworthy that Jones alleges that “boutique practice
reduces medicine to a commodity, unacceptably diminishing pro-
fessionalism” (italics added). From an economic standpoint, a
commodity is a type of service or product that is undifferentiated
and can be readily replicated. Indeed, their ready availability is the
reason why most commodity services are very price-elastic and
therefore relatively inexpensive. Consumers are not willing to pay
higher prices for services that are easily copied and are not distin-
guished by the quality of the provider of such services (such as dry
cleaners). What physicians are attempting to do by providing
boutique medicine is to differentiate themselves in the marketplace
by providing perceived specialized services. Ethical or not, the
result is not medicine as a commodity; if anything, boutique
medicine provides a highly differentiated product and service that
lies far from the definition of an economic commodity.
Perhaps this differentiation is what leads Jones to suggest that
a boutique medical practice will result in a 2-tiered system of
medicine. Arguably, the US health care system is already multit-
iered, with an increasing number of underinsured health care
recipients (including Medicare recipients without supplemental
coverage) being added to the dichotomy of fully insured and
uninsured populations.1 Levels of care and access to appropriate
services correlate to some degree to the “tier”; boutique medicine
likely represents a fourth level of health care access. As Uwe
Reinhardt2 has noted, concierge medicine is not qualitatively
different from limiting insurance participation; it is just a creative
extension of limiting care by class to improve profits.
Finally, one must wonder about the economic feasibility of
providing boutique surgical services. These services, unlike those
provided in primary care, are quite episodic; a patient may, in fact,
not need such services for decades. It seems highly unlikely that
patients would therefore pay a retainer for boutique surgical care.
Concierge care may in fact be unethical. It does not, however,
reduce medicine to a commodity and is fundamentally no different
from physicians’ refusal to participate in low-paying insurance
plans, such as Medicaid. Analysis of the ethics of a boutique
medical practice should lead providers and consumers to a reap-
praisal of the national US health care system. And at any rate,
concierge surgical care may be only of academic concern. Very
likely, there will not be much of a market for it.
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Reply
We thank Drs Akbari and Henochowicz for their comments
on our critique of boutique medical practice. Our criticisms of the
practice were based on a concept at the core of medical ethics, the
physician as the patient’s fiduciary. We argued that the commodity
typically sold in these premium-priced programs—special access to
the physician’s care—serves the economic self-interest of physi-
cians without offering any improvement in the quality of care to be
provided, and inevitably does so by making physician access more
difficult for the clinic’s patients who have not elected to pay the
premium for the first-class plan. Drs Akbari and Henochowicz
appear not to contest this formulation, and concentrate their
objections upon alternative definitions of the term commodity, for
which they provide a description of the sort normally associated
with economic discourse.
This objection involves a pair of significant and related errors.
The first is that economic definitions and values outweigh all other
considerations, but Drs Akbari and Henochowicz provide no
argument to support this view. With their first mistaken assump-
tion unsupported, the second is something of an inevitability: a
specious reductionism in the economic definition of “commodity”
to its differentiation, which overlooks the word’s historical sense.
“Commodity” shares its etymology with “accommodate” and,
curiously, “commode.” “A commodity was a convenience, then an
opportunity, then an advantage, then a thing to sell at an advan-
tage, merchandise.”1 The authoritative dictionaries variously de-
fine commodities as economic goods, articles of commerce, things
useful or valued subject to ready exchange or exploitation within a
market; or as a mass-produced unspecialized product, an economic
unit useful in manufacturing.
Drs. Akbari and Henochowicz’s contention that “from an
economic standpoint, a commodity is a type of service or product
which is undifferentiated and can be readily replicated” is true, but
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